Companies / Consumer Discretionary
WYNN
Wynn Resorts
Casinos & Gaming
Casinos & GamingAnalysis in progress
In progress
We are decoding this company's strategy and relationships
New analyses are published every weekday. Founding members get them first.
Business at a glance
Operating-health scores describe reported fundamentals on a 0–100 scale. They are not a rating of the stock. How they work
Operating health58
Growth57
Profitability44
Cash generation69
Balance sheet18
Dilution control99
Key ratios and five-year financials
Latest quarter revenue YoY (2026-09-30)-7.9%Revenue growth (FY)0.1%Revenue CAGR (3y)23.9%Gross margin—Operating margin15.7%Net margin4.6%Free cash flow margin9.7%R&D / revenue—Stock comp / revenue1.3%Net debt / operating cash flow6.72xCurrent ratio1.63Diluted share count change-5.5%
| Fiscal year ending | FY 2021-12 | FY 2022-12 | FY 2023-12 | FY 2024-12 | FY 2025-12 |
|---|---|---|---|---|---|
| Revenue | $3.8B | $3.8B | $6.5B | $7.1B | $7.1B |
| Operating income | -$395M | -$101M | $840M | $1.1B | $1.1B |
| Net income | -$756M | -$424M | $730M | $501M | $327M |
| Operating cash flow | -$223M | -$71M | $1.2B | $1.4B | $1.4B |
| Capital expenditure | $291M | $300M | $443M | $420M | $660M |
| Free cash flow | -$513M | -$371M | $805M | $1.0B | $692M |
| Stock-based comp | $95M | $68M | $65M | $59M | $92M |
| Buybacks | $14M | $187M | $212M | $402M | $380M |
| Dividends | $2M | $1M | $85M | $140M | $175M |
| Cash | $2.5B | $3.7B | $2.9B | $2.4B | $1.5B |
| Total debt | $12.0B | $12.7B | $12.4B | $10.6B | $10.6B |
| Equity | -$214M | -$751M | -$251M | -$224M | -$275M |
StratGraph publishes general, impersonal research about public companies based on public filings. It is not investment advice, not a recommendation to buy, sell or hold any security, and not tailored to any reader's circumstances. Content may contain errors and may be partly generated with AI tools; verify against the original filings, which are linked. Authors may not trade securities discussed within the window set by our trading policy. Full disclaimer.